跳至主要内容
临床试验/JPRN-UMIN000007975
JPRN-UMIN000007975已完成2 期

Effect of Daikenchuto on Postoperative Bowel Motility and on Prevention of Paralytic Ileus after Pancreaticoduodenectomy A Multicenter, Randomized, Placebo-controlled Phase II trial - The JAPAN-PD Study

Wakayama Medical University0 个研究点目标入组 220 人开始时间: 2012年8月22日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • i)Clinically problematic cardiac disease. ii)Liver cirrhosis or active hepatitis. iii)Severe pulmonary disease (interstitial pneumonia, pulmonary fibrosis, pulmonary emphysema etc.). iv)Chronic renal failure requiring hemodialysis. v)Other malignant disease that can influence the adverse effect. vi)Patients with tumors requiring resection of colon. vii)Patients who are expected to have severe intra-abdominal adhesion due to past surgical history or past peritonitis history. viii)Patients who had used gastrointestinal prokinetic medication, antipsychotic medication or antidepressants. ix)Patients who had used Japanese herbal (Kampo) medicines within 4 weeks before registration. x)Pregnant or lactating women. xi)Any other medical condition that makes the patient unsuitable for inclusion in the study according to the opinion of the investigator.

研究者

相似试验